StopDownOpen the app

Launch · Agriculture & Food Systems

Lemnisca builds digital twin for bioprocess scale-up

By ·

Date
Company
Lemnisca
What it does
Digital twin platform for fermentation
Kind
Launch
Stage
pre-seed
Sector
Agriculture & Food Systems

What they do

Lemnisca is building a digital twin platform that simulates fermentation to help biotech manufacturers scale bioprocesses from lab to industrial volumes

What happened

The startup, founded by Shilpa Nargund and Pushkar Pendse, has built in-house wet lab capabilities to improve model accuracy and plans to take on one or two…

Why it matters

India's bio-economy has surged 16-fold to $165.7 billion in the last decade, and the global bioprocessing industry is growing at 11.39% CAGR to $228.73…

The details

  • Lemnisca is building a digital twin platform for fermentation to help biotech manufacturers scale bioprocesses from lab to industrial volumes.
  • The platform uses a hybrid model that simulates living cell behaviour and physical conditions to predict bioprocess outcomes at scale.
  • The startup has built in-house wet lab capabilities to generate data for improving the accuracy of its digital twin model.
  • Lemnisca is agnostic to industry or product type; any molecule naturally made can be produced with microbes.
  • The company plans to take on one or two microbial processes in 2025, creating a specific product like a chemical or protein.
  • Its next milestone is to prove the technology is innovative and fit for a manufacturing setting.
  • Future growth could be horizontal (more processes across customers or molecule types) or vertical (multiple steps in manufacturing for one molecule).
  • The startup plans to cater equally to Indian and international customers.

The bigger picture

  • India's bio-economy has surged 16-fold to $165.7 billion in the last 10 years.
  • The global bioprocessing industry is growing at 11.39% CAGR to $228.73 billion by 2033.
  • The Union Budget FY27 allocated ₹10,000 crore for the Biopharma Shakti scheme over five years to boost biologics and biosimilars.
  • India is the third-largest biotech market in Asia-Pacific and top 12 globally, but its share in the global biotech market is below 3%.
  • Lemnisca's digital twin for bioprocessing is unique in the Indian context.

About the business

  • Lemnisca builds a digital twin platform for fermentation processes.
  • The platform uses a hybrid model simulating living cell behaviour and physical conditions.
  • It predicts bioprocess outcomes at scale, helping manufacturers move from lab to industrial volumes.
  • The startup has in-house wet lab capabilities to generate data for model accuracy.
  • Lemnisca is agnostic to industry or product type; any molecule naturally made can be produced with microbes.

What happens next

  • Take on one or two microbial processes in 2025, creating a specific product like a chemical or protein.
  • Prove the technology is innovative and fit for a manufacturing setting.
  • Future growth could be horizontal (more processes across customers or molecule types) or vertical (multiple steps in manufacturing for one molecule).
  • Cater equally to Indian and international customers.

The deal

Type
launch

Founders

  • Shilpa Nargund, founder
  • Pushkar Pendse, co-founder

Other articles talking about it

Read it as a card in the app

Same day

All startup news on 28 February 2026 →